Progress Reports
- Australian Clinical Trials Int. Report
- WA Biotechnology Directory
- Australian Clinical Trials Registry
- GMDN Registration
- ACTR Press Release
Australian TGA approves Medex Test Device System Registration
It is thrilling to announce that the Medex Test system has obtained full approval by the Australian Therapeutic Goods Administration (TGA), as well as Global Medical Device Nomenclature (GMDN) registration.
The formal classifications of our licenses with the international registry body, GMDN, are as follows:
Neurologic device for examination of physiological conditions of dermatome-visceral connections application program software.
- Screening device for test of electrical resistance of dermatome-visceral zones application program software.
- Measured device for screening of conditions of internal organs application program software.
- Neurologic device for screening of internal organs disorders application program software
Medex Test is a fast, non-invasive, accurate, radiation-free, and significantly less expensive early diagnostic screening tool. Health benefit funds and insurers should be particularly interested on behalf of their members. We believe every doctor and health-care professional should have this device in their clinics to provide a better qualified standard of diagnosis to their patients.
CE Certification
Medex Test has received European CE and Health Ministry certification as an early stage diagnostic screening device for internal organ disorders. Device calibration follows Siemens (Germany) strict specification standards protocol prior to product distribution to hospitals and general practitioners
